Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline versus ceftriaxone for adult community-acquired pneumonia
2007-000599-18Phase 3Completed
- Sponsor
- Cerexa
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in community-acquired pneumonia (CAP) comparing Ceftaroline arm with Ceftriaxone arm (2 arms). Primary endpoints: Overall success rate at test-of-cure in clinically evaluable population and Overall success rate at test-of-cure in modified intent-to-treat population. Started Apr 2007; status: completed.
02
Drugs
ceftaroline fosamilceftriaxone
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2007-000599-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000599-18.